- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有398家主力机构披露2024-12-31报告期持股数据，持仓量总计1.53亿股，占流通A股38.24%
- 波段诊断：
-
技术面诊股
诊断结果：6.2技术面打败了42%的股票
技术面评分前10的股票
近期的平均成本为101.56元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为101.56元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"101.56","date":1752738769,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2025.07.18","stock":"-0.78","trade":"1.02","ind":"0.37"},{"date":"2025.07.17","stock":"3.19","trade":"2.77","ind":"1.43"},{"date":"2025.07.16","stock":"0.01","trade":"0.80","ind":"-0.22"},{"date":"2025.07.15","stock":"-1.24","trade":"-0.24","ind":"0.56"},{"date":"2025.07.14","stock":"-1.30","trade":"1.29","ind":"-0.11"},{"date":"2025.07.11","stock":"0.59","trade":"1.39","ind":"0.61"},{"date":"2025.07.10","stock":"-0.11","trade":"0.92","ind":"0.47"},{"date":"2025.07.09","stock":"0.27","trade":"-0.28","ind":"-0.06"},{"date":"2025.07.08","stock":"0.94","trade":"0.18","ind":"1.46"},{"date":"2025.07.07","stock":"-5.62","trade":"-1.65","ind":"-0.70"},{"date":"2025.07.04","stock":"0.13","trade":"0.46","ind":"-0.25"},{"date":"2025.07.03","stock":"10.00","trade":"2.86","ind":"1.17"},{"date":"2025.07.02","stock":"-1.19","trade":"-1.57","ind":"-0.61"},{"date":"2025.07.01","stock":"0.83","trade":"2.52","ind":"0.11"},{"date":"2025.06.30","stock":"0.57","trade":"1.47","ind":"0.83"},{"date":"2025.06.27","stock":"1.20","trade":"0.85","ind":"0.34"},{"date":"2025.06.26","stock":"-1.48","trade":"-1.31","ind":"-0.48"},{"date":"2025.06.25","stock":"-0.57","trade":"0.29","ind":"1.72"},{"date":"2025.06.24","stock":"0.77","trade":"1.81","ind":"1.68"},{"date":"2025.06.23","stock":"-0.28","trade":"1.50","ind":"0.43"},{"date":"2025.06.20","stock":"-1.01","trade":"0.27","ind":"-0.47"}]
长春高新,深证成指,生物制品指数
压力支撑
该股压力位为101.57元，支撑位为100.60元。
[{"text":"\u538b\u529b\u4f4d","value":"101.57","date":1752768000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"100.60","date":1752768000,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了21%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：07月18日 20:30
| 机构今日流向(万元) | -689.05 | 机构5日流向(万元) | 2062.54 |
| 机构10日流向(万元) | -2266.04 | 机构20日流向(万元) | -3084.45 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量增加291.03万股，其中基金数没有增加，主力净减仓50家，暂未发现中长期投资价值。
截止2024-12-31，共398家主力机构（基金395家，一般法人3家），持仓量总计15281.92万股，占流通A股38.24%
其中，基金持仓与2024-06-30相比：
增仓：116家 ，增持 838.43万股
减仓：116家 ，减持 129.29万股
新出现在主力名单中：120家 ，持有1052.58万股
从主力名单中消失：170家 ，原持有1199.71万股
其中，基金持仓与2024-06-30相比：
增仓：116家 ，增持 838.43万股
减仓：116家 ，减持 129.29万股
新出现在主力名单中：120家 ，持有1052.58万股
从主力名单中消失：170家 ，原持有1199.71万股
消息面诊股
诊断结果：6.2消息面打败了72%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业周报|生物制品指数涨5.74%, 跑赢上证指数
2025-07-18 - 长春高新：7月17日获融资买入8565.81万元，
2025-07-18 - 第十一批药品集采启动，竞价规则优化！医药行业迎来新
2025-07-18 - 长春高新：7月16日获融资买入4863.43万元，
2025-07-17 - 长春高新：7月14日获融资买入6742.47万元
2025-07-15 - 券商观点|医药行业周报：国内新药市场将持续发力
2025-07-14 - 长春高新：7月11日获融资买入6681.41万元，
2025-07-14 - 道通科技目标价涨幅超65%，长春高新评级被调低
2025-07-14 - 长春高新：产品BD受意愿、价格等因素影响存在不确定
2025-07-11 - 长春高新：公司通过持续增强研发实力努力提升长期盈利
2025-07-11
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-21 |
| 利好 | 分红转增 | 10派26元(含税) | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 工作安排 | 2024-09-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-20 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.2行业面打败了93%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2025.07.18","price":"0.37","value":"1.02"},{"date":"2025.07.17","price":"1.43","value":"2.77"},{"date":"2025.07.16","price":"-0.22","value":"0.80"},{"date":"2025.07.15","price":"0.56","value":"-0.24"},{"date":"2025.07.14","price":"-0.11","value":"1.29"},{"date":"2025.07.11","price":"0.61","value":"1.39"},{"date":"2025.07.10","price":"0.47","value":"0.92"},{"date":"2025.07.09","price":"-0.06","value":"-0.28"},{"date":"2025.07.08","price":"1.46","value":"0.18"},{"date":"2025.07.07","price":"-0.70","value":"-1.65"},{"date":"2025.07.04","price":"-0.25","value":"0.46"},{"date":"2025.07.03","price":"1.17","value":"2.86"},{"date":"2025.07.02","price":"-0.61","value":"-1.57"},{"date":"2025.07.01","price":"0.11","value":"2.52"},{"date":"2025.06.30","price":"0.83","value":"1.47"},{"date":"2025.06.27","price":"0.34","value":"0.85"},{"date":"2025.06.26","price":"-0.48","value":"-1.31"},{"date":"2025.06.25","price":"1.72","value":"0.29"},{"date":"2025.06.24","price":"1.68","value":"1.81"},{"date":"2025.06.23","price":"0.43","value":"1.50"},{"date":"2025.06.20","price":"-0.47","value":"0.27"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 神州细胞 | 88.15% | 14.80% | 6.5分 |
| 2 | 康辰药业 | 85.09% | 24.69% | 6.8分 |
| 3 | 迈威生物 | 48.95% | 13.44% | 6.5分 |
| 4 | 百普赛斯 | 37.77% | 4.01% | 4.7分 |
| 5 | 欧林生物 | 36.60% | 25.93% | 7.2分 |
| 6 | 康弘药业 | 34.26% | 22.33% | 7.1分 |
| 8 | 近岸蛋白 | 29.34% | 15.71% | 5.6分 |
| 10 | 我武生物 | 25.57% | 15.42% | 6.7分 |
| 12 | 百奥泰 | 21.86% | 12.97% | 6.8分 |
| 14 | 君实生物 | 18.59% | 5.33% | 6.1分 |
| 16 | 荣昌生物 | 17.49% | 13.55% | 6.8分 |
| 18 | 艾迪药业 | 16.65% | 7.76% | 6.7分 |
| 20 | 安科生物 | 16.08% | 6.31% | 6.7分 |
| 22 | 康泰生物 | 13.31% | -1.57% | 5.6分 |
| 24 | 优宁维 | 12.23% | 1.99% | 5.5分 |
| 26 | 通化东宝 | 11.20% | 3.39% | 6.6分 |
| 28 | 东宝生物 | 10.24% | 1.54% | 5.6分 |
| 30 | 博晖创新 | 9.84% | 0.48% | 5.4分 |
| 32 | 甘李药业 | 9.75% | 5.25% | 7.1分 |
| 34 | 三生国健 | 8.72% | 4.19% | 6.6分 |
| 36 | 昊帆生物 | 8.40% | 2.89% | 5.6分 |
| 38 | 西藏药业 | 6.38% | 2.95% | 6.5分 |
| 40 | 赛升药业 | 6.03% | 8.60% | 5.5分 |
| 42 | 华兰生物 | 4.77% | 1.94% | 6.3分 |
| 44 | 天坛生物 | 3.92% | 1.17% | 6.5分 |
| 46 | 沃森生物 | 2.89% | -1.47% | 4.7分 |
| 48 | - | -14.94% | -0.12% | 分 |
| 50 | 成大生物 | - | 4.43% | 5.2分 |
| 52 | *ST四环 | - | -1.24% | 5.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 11/72 ， 12/72。
[{"date":"2025-03-31","value":"2.03","vol":"0.63"},{"date":"2024-12-31","value":"11.46","vol":"-0.24"},{"date":"2024-09-30","value":"12.38","vol":"1.37"},{"date":"2024-06-30","value":"7.82","vol":"0.72"},{"date":"2024-03-31","value":"3.82","vol":"0.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.03 | 11.46 | 12.38 | 7.82 | 3.82 |
| 行业(%) | 0.63 | -0.24 | 1.37 | 0.72 | 0.41 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"88.22","vol":"69.78"},{"date":"2024-12-31","value":"85.72","vol":"69.97"},{"date":"2024-09-30","value":"85.60","vol":"70.57"},{"date":"2024-06-30","value":"84.62","vol":"69.89"},{"date":"2024-03-31","value":"83.43","vol":"70.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
88.22 | 85.72 | 85.60 | 84.62 | 83.43 |
| 行业(%) | 69.78 | 69.97 | 70.57 | 69.89 | 70.42 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 35/72 ， 39/72。
[{"date":"2025-03-31","value":"-5.66","vol":"6246.12"},{"date":"2024-12-31","value":"-7.55","vol":"48.20"},{"date":"2024-09-30","value":"-2.75","vol":"178.44"},{"date":"2024-06-30","value":"7.63","vol":"19.75"},{"date":"2024-03-31","value":"14.39","vol":"31.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.66 | -7.55 | -2.75 | 7.63 | 14.39 |
| 行业(%) | 6246.12 | 48.20 | 178.44 | 19.75 | 31.66 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-44.95","vol":"-7.36"},{"date":"2024-12-31","value":"-43.01","vol":"-10.38"},{"date":"2024-09-30","value":"-22.80","vol":"-53.42"},{"date":"2024-06-30","value":"-20.40","vol":"-9.25"},{"date":"2024-03-31","value":"0.20","vol":"-535.57"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-44.95 | -43.01 | -22.80 | -20.40 | 0.20 |
| 行业(%) | -7.36 | -10.38 | -53.42 | -9.25 | -535.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 10/72 ， 46/72。
[{"date":"2025-03-31","value":"0.10","vol":"0.06"},{"date":"2024-12-31","value":"0.44","vol":"0.29"},{"date":"2024-09-30","value":"0.34","vol":"0.22"},{"date":"2024-06-30","value":"0.22","vol":"0.14"},{"date":"2024-03-31","value":"0.10","vol":"0.07"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.44 | 0.34 | 0.22 | 0.10 |
| 行业(次) | 0.06 | 0.29 | 0.22 | 0.14 | 0.07 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.07","vol":"0.26"},{"date":"2024-12-31","value":"0.40","vol":"1.19"},{"date":"2024-09-30","value":"0.31","vol":"0.87"},{"date":"2024-06-30","value":"0.21","vol":"0.55"},{"date":"2024-03-31","value":"0.11","vol":"0.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.07 | 0.40 | 0.31 | 0.21 | 0.11 |
| 行业(次) | 0.26 | 1.19 | 0.87 | 0.55 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"19.05","vol":"-47.52"},{"date":"2024-12-31","value":"0.27","vol":"-9.01"},{"date":"2024-09-30","value":"29.83","vol":"-29.47"},{"date":"2024-06-30","value":"24.32","vol":"-36875.39"},{"date":"2024-03-31","value":"35.75","vol":"-44804.94"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 19.05 | 0.27 | 29.83 | 24.32 | 35.75 |
| 行业 | -47.52 | -9.01 | -29.47 | -36875.39 | -44804.94 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.27","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"3.05","vol":"2.72"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 3.27 | - | 3.05 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.72 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 28/72 ， 25/72。
[{"date":"2025-03-31","value":"4.32","vol":"7.90"},{"date":"2024-12-31","value":"4.76","vol":"6.83"},{"date":"2024-09-30","value":"4.89","vol":"7.16"},{"date":"2024-06-30","value":"4.82","vol":"7.04"},{"date":"2024-03-31","value":"4.59","vol":"8.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.32 | 4.76 | 4.89 | 4.82 | 4.59 |
| 行业 | 7.90 | 6.83 | 7.16 | 7.04 | 8.08 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.67","vol":"6.47"},{"date":"2024-12-31","value":"3.07","vol":"5.50"},{"date":"2024-09-30","value":"3.26","vol":"5.77"},{"date":"2024-06-30","value":"3.20","vol":"5.91"},{"date":"2024-03-31","value":"3.16","vol":"6.93"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.67 | 3.07 | 3.26 | 3.20 | 3.16 |
| 行业 | 6.47 | 5.50 | 5.77 | 5.91 | 6.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 28/72 ， 27/72。
[{"date":"2025-03-31","value":"16.20","vol":"25.48"},{"date":"2024-12-31","value":"15.94","vol":"25.46"},{"date":"2024-09-30","value":"16.28","vol":"24.92"},{"date":"2024-06-30","value":"16.89","vol":"24.62"},{"date":"2024-03-31","value":"15.74","vol":"23.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.20 | 15.94 | 16.28 | 16.89 | 15.74 |
| 行业(%) | 25.48 | 25.46 | 24.92 | 24.62 | 23.98 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.22","vol":"0.78"},{"date":"2024-12-31","value":"0.22","vol":"0.88"},{"date":"2024-09-30","value":"0.22","vol":"0.41"},{"date":"2024-06-30","value":"0.23","vol":"0.38"},{"date":"2024-03-31","value":"0.21","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.22 | 0.22 | 0.22 | 0.23 | 0.21 |
| 行业(%) | 0.78 | 0.88 | 0.41 | 0.38 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 光大证券 | 2025-07-08 | 增持 | |
| 湘财证券 | 2025-07-03 | 增持 | 增持 |
| 国盛证券 | 2025-05-29 | 买入 | |
| 浙商证券 | 2025-05-28 | 增持 | |
| 中泰证券 | 2025-05-19 | 买入 | 买入 |
| 海通国际 | 2025-05-15 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"37.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"41.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"45.32","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.83","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"25.65","blueLineValue":"6.29","type":"YC"}]